Nucala - direct healthcare professional communication (DHPC)

Mepolizumab
DHPCHuman

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Par

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumenti

Direct healthcare professional communication (DHPC): Shortage of Nucala (mepolizumab) Pre-Filled Pen (EU/1/15/1043/003, EU/1/15/1043/004)

English (EN) (174.93 KB - PDF)

Pirmo reizi publicēts:
Skatīt

Key facts

Medicine name
Nucala
Active substance
Mepolizumab
Therapeutic area (MeSH)
Asthma
DHPC type
Medicine shortage
Human ATC codes
R03DX09
Dissemination date

Share this page